Volume 7 Issue 4
Jul.  2016
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2016  >  7(4): 283-286
Zhou Jing, Lei Lianhui, Tian Eryun, et al. Application of double filtration plasmapheresis in ABO-incompatible liver transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(4): 283-286. doi: 10.3969/j.issn.1674-7445.2016.04.007
Citation: Zhou Jing, Lei Lianhui, Tian Eryun, et al. Application of double filtration plasmapheresis in ABO-incompatible liver transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(4): 283-286. doi: 10.3969/j.issn.1674-7445.2016.04.007
shu

Application of double filtration plasmapheresis in ABO-incompatible liver transplantation

doi: 10.3969/j.issn.1674-7445.2016.04.007

  • Department of Intensive Care Medcine, General Hospital of Chinese People's Armed Police, 100039 Beijing, China

  • Received Date: 2016-04-02
    Available Online: 2021-01-19
  • Publish Date: 2016-07-15
    Abstract
  •   Objective  To observe the clinical efficacy and safety of double filtration plasmapheresis (DFPP) in eliminating blood group antibody in ABO-incompatible patients undergoing liver transplantation.   Methods  Eighteen recipients with ABO-incompatible liver transplantation in the General Hospital of Chinese People's Armed Police from January 2012 to December 2014 were selected in the ABO-incompatibility group. The recipients with an antibody titer of anti-A or anti-B blood group>1∶16 were scheduled to undergo DFPP. Another 20 recipients eligible for blood transfusion were chosen into the control group. The changes in the antibody titer, blood biochemical parameters and the incidence of complications were observed in recipients with ABO-incompatible liver transplantation. The incidence of acute rejection and mortality rate between the ABO incompatibility group and control group were statistically compared.   Results  Among 18 patients, 15 with an antibody titer of anti-A or anti-B blood group>1∶16 received DFPP. After DFPP, the mean antibody titer was significantly declined. Detection of blood biochemical parameters indicated that the level of fibrinogen was significantly decreased following DFPP (P=0.0001). Among 20 cases receiving DFPP, 3 cases presented with hypotension, 3 with hemorrhage, 1 with nausea and vomiting, and 1 with coagulation in pipeline. All symptoms were alleviated after effective treatment. The incidence of acute rejection and mortality rate did not significantly differ between the ABO-incompatibility group and control group after DFPP (both P>0.05).   Conclusion  DFPP can safely and effectively reduce the level of blood group antibody, decrease the incidence of acute rejection after liver transplantation and enhance the success rate of liver transplantation.

     

    • FullText(HTML)
  • loading
    • References(16)
  • [1]
    沈中阳,邓永林,郑虹,等.ABO血型不合肝移植治疗急危重症肝病患者的临床疗效分析[J].中华危重病急救医学,2014,26(8):529-533.

    Shen ZY, Deng YL, Zheng H, et al. Analysis of the curative effect of ABO-incompatible liver transplantation in the treatment in patients with acute severe liver disease[J]. Chin Crit Care Med, 2014,26(8):529-533.
    [2]
    阎冰,李捷,郭文治,等. ABO血型不合肝移植术后急性抗体介导的排斥反应研究进展[J/CD].中华肝脏外科手术学电子杂志,2014,3(2):124-126.

    Yan B, Li J, Guo WZ, et al. Research progress on antibody mediated rejection after liver transplantation with ABO-incompatibility[J/CD]. Chin J Hepatic Surg(Electr Edit),2014,3(2):124-126.
    [3]
    吴李贤, 叶一农, 何宏亮,等. 血浆置换联合持续性血液透析滤过治疗肝衰竭的疗效分析[J]. 热带医学杂志, 2014, 14(4):481-484. http://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201404021.htm

    Wu LX, Ye YN, He HL, et al. Effect of plasma exchange combined with continuous hemodiafiltration on the treatment of liver failure[J]. J Trop Med, 2014, 14(4):481-484. http://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201404021.htm
    [4]
    Lumlertgul D, Suteeka Y, Tumpong S, et al. Double filtration plasmapheresis in different diseases in Thailand[J]. Ther Apher Dial,2013,17(1):99-116. doi: 10.1111/tap.2013.17.issue-1
    [5]
    Tanabe K. Double-filtration plasmapheresis[J]. Transplantation, 2007,84(12 Suppl):S30-S32. http://cn.bing.com/academic/profile?id=2033562197&encoded=0&v=paper_preview&mkt=zh-cn
    [6]
    Tsai MK, Wu MS, Yang CY, et al. B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis[J]. J Formos Med Assoc,2015,114(4):353-358. doi: 10.1016/j.jfma.2012.12.012
    [7]
    Thorsen T, Dahlgren US, Aandahl EM, et al. Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications[J]. Transpl Int,2015,28(7):800-812. doi: 10.1111/tri.12552
    [8]
    Demetris AJ, Zeevi A, O'Leary JG. ABO-compatible liver allograft antibody-mediated rejection: an update[J]. Curr Opin Organ Transplant,2015,20(3):314-324. doi: 10.1097/MOT.0000000000000194
    [9]
    Shen T, Lin BY, Jia JJ, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure[J]. Hepatobiliary Pancreat Dis Int,2014,13(4):395-401. doi: 10.1016/S1499-3872(14)60268-X
    [10]
    Tiwari AK, Pandey P, Aggarwal G, et al. Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT)[J]. Transplant Res,2014, 3 :17. doi: 10.1186/2047-1440-3-17
    [11]
    江春平,丁义涛,徐庆祥,等.ABO血型不合供肝在肝移植中的应用[J/CD].实用器官移植电子杂志, 2013, 1 (1):27-30.

    Jiang CP, Ding YT, Xu QX, et al. Application of liver grafts from ABO incompatible donor[J/CD]. Pract J Organ Transplant (Electr Vers) , 2013, 1 (1):27-30.
    [12]
    Kim JM, Kwon CH, Joh JW, et al. ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor[J]. J Hepatol,2013,59(6):1215-1222. doi: 10.1016/j.jhep.2013.07.035
    [13]
    Abe M, Sannomiya A, Koike T, et al. Removal of anti-donor antibody by double-filtration plasmapheresis to prevent chronic rejection in kidney transplantation[J]. Transplant Proc,1998,30(7):3108-3109. doi: 10.1016/S0041-1345(98)00952-X
    [14]
    陈立中, 陈国栋. ABO血型不相容活体肾移植的热点评析[J]. 器官移植, 2013, 4(4):187-190. http://www.organtranspl.com/browse/detail/qkid/65/id/346.html

    Chen LZ, Chen GD. ABO-incompatible living donor kidney transplantation[J]. Organ Transplant, 2013, 4(4):187-190. http://www.organtranspl.com/browse/detail/qkid/65/id/346.html
    [15]
    Sanada Y, Mizuta K, Urahashi T, et al. Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study[J]. Ther Apher Dial,2012,16(4):368-375. doi: 10.1111/tap.2012.16.issue-4
    [16]
    Hanafusa N1, Hamasaki Y, Kawarasaki H, et al. The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation[J]. Transfus Apher Sci,2013,49(2):254-258. doi: 10.1016/j.transci.2013.06.004
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (65) PDF downloads(16) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return